Maharashtra, a traditional hub of the Indian pharma industry, could face an uphill task to retain its decades-old dominance in…
Suresh G Kare, Chairman, Indoco Remedies, elaborates why Maharashtra has been a preferred destination for the pharma sector
Shashank Sandu, Director, Sandu Pharmaceuticals, elaborates on how Maharashtra has become a favourite destination for pharma cos
It is only five months since India’s central drug authority launched its online licensing services portal, SUGAM. But the regulator…
Dinesh Chindarkar, Co-Founder of MediaMedic Communications, elaborates on how pharma marketing is undergoing a paradigm shift with the advent of…
Though the life sciences sector has stored some good points in Union Budget 2016, it has evoked a mixed response…
Will the bullish response to last year’s IPOs in the pharma and healthcare sector spur more companies to test the…
Pharma MSMEs will miss the Make in India bus unless they upgrade to global norms. But industry stalwarts point out…
Industry stakeholders share their wish list for the pharma industry from the forthcoming budget
Securing the supply chain, environmental sustainability and updation of technology infrastructure will be the buzzwords. By Usha Sharma
ASPA’s objective is to curb counterfeit products in various sectors and create an awareness programme on how to identify correct…
Richard Nemesi, Global Vertical Manager for Pharmaceutical and Medical Devices, Videojet Technologies, opines that the main challenge is the sheer…
More than a year after the ‘Make in India campaign’ was launched, pharma manufacturers are divided on its impact. Will…
Engineering Export Promotion Council (EEPC) India, the premier council of engineering exporters, is going to be the organiser of International…
Will Director Dr Partap Chauhan’s focus on the global market and other forays like ayurvedic telemedicine succeed in achieving revenue…
After establishing successful business strategies in the pharma segment, Himalaya Drug Company is expanding its niche in the baby care…
With health at the core of several initiatives driven by the Centre, how can we translate political rhetoric into sustainable…
In three decades, Bliss GVS has emerged as a Rs 400-crore niche player in suppositories and pessaries By Usha Sharma